HemaXis

HemaXis is the commercial brand of Swiss medtech company DBS System, which develops microfluidic blood microsampling devices for decentralized collection, storage, transport, and laboratory analysis of capillary blood. Its core products are HemaXis DB/DB10, a CE/IVD and FDA Class 1 whole-blood collection device, and HemaXis DX, a next-generation plasma/serum separation device that remains in development for research use. The company positions its platform as a way to replace conventional venous sampling workflows with standardized fingertip microsamples that can fit existing laboratory automation and dried-blood-spot workflows. HemaXis serves clinical laboratories, pharmaceutical research, biomarker testing, therapeutic drug monitoring, toxicology, and other diagnostic applications. The business is best characterized as a diagnostics and sample-collection device company rather than a therapeutics developer.